WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke VISCOFAN FIBERCOLL-FLEX wurde als Wortmarke am 28.07.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1690740 |
| Länder | 
|
| Basismarke |
Nr. 018736010,
21. Juli 2022
|
| Anmeldedatum | 28. Juli 2022 |
| Ablaufdatum | 28. Juli 2032 |
Markeninhaber
C/ Berroa nº 15 4ª pl.
Polígono Industrial Berroa
ES
Polígono Industrial Berroa
ES
Markenvertreter
Calle Cedaceros, 1
E-28014 Madrid
ES
Waren und Dienstleistungen
01
Biological materials or preparations for 3D printers,
hydrogels for cell culture; hydrogels for cell growth; cell
culture media (other than for medical or veterinary use);
nutritional agents for processing living cells (other than
for medical use); culture media for microbiology; reagents
for scientific and medical research; synthetic peptides (not
for pharmaceutical purposes); synthetic peptide derivatives
(not for pharmaceutical purposes); cells (other than for
medical, veterinary or pharmaceutical use); cells or tissues
in hydrogels (other than for medical, veterinary or
pharmaceutical use); biologically compatible polymers,
specifically hydrogels used to produce polymer networks used
in the manufacture of engineered living tissues for medical,
scientific and non-scientific purposes; cell culture media
for use in the biotechnological industry; cell culture media
for use in non-medical research laboratories; biological
preparations for use in cell culture, other than for medical
and veterinary purposes; engineered living tissues and
tissue arrays, namely, human and animal organs, connective
tissue, epithelial tissue, muscular tissue and nervous
tissue, and tissue arrays, for use in scientific and medical
research; biologically compatible materials, specifically,
hydrogels used to create polymeric networks used in the
manufacture of living tissues; proteins in the form of raw
materials for scientific and medical research
02
Inks of biological origin for printers; inks of biological
origin for 3D printers
05
Hydrogels for medical, veterinary and pharmaceutical
purposes for cellular biology applications; hydrogels for
cell growth, cell growth and transplantation, assays based
on cells, cancer cell research, regenerative medicine, stem
cell growth and drug delivery; hydrogels for cell culture
for medical, veterinary and pharmaceutical purposes;
hydrogels for cell growth for medical, veterinary and
pharmaceutical purposes; cell culture media; nutritional
agents for processing living cells; synthetic peptides;
synthetic peptide derivatives; cells for medical, veterinary
and pharmaceutical use; cells or tissues in hydrogels for
medical, veterinary or pharmaceutical use; pharmaceutical
preparations for use in 3D bio-printing of tissues and
organs; pharmaceutical preparations based on cellulose
nanofibers for use in 3D bio-printing of tissues and organs;
regenerative tissue [pharmaceutical preparations]; cells for
medical use; allogeneic human tissue; living cells for
medical use; implantation of living tissue with controlled
tissue regeneration; implants containing living tissue;
implantable living tissue materials for use in guided tissue
regeneration; skin grafts; surgical implants formed by
living tissue; surgical implants of living tissues derived
from stem cells; transdermal patches for the creation of
skin for prostheses and skin grafts; living tissue for
transplants; engineered biological tissues and organs,
namely, human and animal cardiovascular, pulmonary,
digestive, hepatobiliary, urological, renal, endocrine,
epithelial, muscular, and nervous tissues and organs, for
medical purposes; biological molecules to assist in tissue
engineering; hemostatic gel matrix preparations for wound
treatment; natural biomaterials for the growth of bones,
blood and tissues for medical purposes; pharmaceutical
products for the regeneration of tissues, for the repair of
tissues, for the treatment of tissues, whether human or
animal; pharmaceutical preparations for the treatment of
diseases of bones, cartilages, blood vessels, nerve cell
degeneration, tendon and ligament degeneration, retinal
degeneration, kidney degeneration; soft tissue
degenerations, for diseases with abnormal cell growth;
natural biomaterial for bone filling; natural biomaterial
for cartilage filling; biological tissue cultures for
medical use; biological tissue cultures for medical
purposes; biological tissue grafts; bone and skin biological
tissues impregnated with oxygen lines for tissue constructs
applicable for increasing the cell survival in tissue
intended for subsequent implants; gene therapy products,
namely, genetically modified tissues for the transplant
thereof; implantable stents containing living tissue to
maintain the structure of the tissue; natural biomaterial
for bone and tissue growth for medical purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 14. Juli 2023 | 2023/28 Gaz | MX | Ablehnung |
| 30. Mai 2023 | 2023/22 Gaz | TR | Ablehnung |
| 22. April 2023 | 2023/17 Gaz | US | Ablehnung |
| 10. April 2023 | 2023/15 Gaz | CN | Ablehnung |
| 22. Februar 2023 | 2023/8 Gaz | PL | Ablehnung |
| 18. Januar 2023 | 2023/3 Gaz | GB | Ablehnung |
| 28. Juli 2022 | 2022/40 Gaz | EM | Eintragung |
ID: 141690740